Prebiotics, the gastrointestinal microbiome and clinical outcomes post allogeneic stem cell transplantatio

Not Applicable

Active, not recruiting

• Conditions: stem cell transplantation; graft versus host disease; enteral nutrition; Diet and Nutrition - Other diet and nutrition disorders; Blood - Haematological diseases

• Registration Number: ACTRN12621000832875
• Lead Sponsor: Royal Brisbane and Womens Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-30
• Last Update Posted: 9 August 2022

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients aged 18 or older undergoing allogeneic myeloablative or reduced intensity myeloablative allogeneic stem cell transplantation at the Royal Brisbane and Womens Hospital who can provide written informed consent.

Exclusion Criteria

Patients already enrolled on a GVHD prevention study, hepatitis B, hepatitis C or HIV infection or intolerance or allergy to any ingredient in the enteral feed.

Study & Design

• Study Type: Interventional
• Study Design: Not specified